Rx for RCC
The C Story. The Big C Magazine, January-March 2007
By: Rosario N. Banzon
Every year, more than 200,000 people all over the world are diagnosed with kidney cancer. For one diagnosed with renal cell carcinoma (RCC), an advanced type of kidney cancer, businessman Manuel V. del Rosario has a lifestyle that has gone back to normal.
Nexavar was approved by the U.S. Food and Drug Administration last year after a comprehensive clinical study was conducted on 903 patients with advanced kidney cancers. The findings showed that Nexavar increased the length of times that the tumors stopped growing – from three months to six months. The European Union also recently approved its use in Europe.
Nexavar is now available in the Philippines, as well as in Chile, Mexico, Brazil, Korea and Argentina.
From a dose of two tablets daily, del Rosario’s dose was increased to four times daily. Recently, however his doctors temporarily stopped the medication when he developed rashes on his legs.
del Rosario was introduced to the treatment by Dr. Sandy Srinivas, an oncologist from Stanford University, who visited the country this year. They met at a health forum held at the Makat Medical Center.
His family, naturally, continues to worry over his health, but del Rosario is upbeat. He attributes his newfound energy to the hope that this new therapy gives him – as well as to the constant spiritual support of healing priest from Canada, Fr. Fernando Suarez.
Being on Nexavar for five months now and putting complete trust in Divine Providence, del Rosario has good reasons to be hopeful.
*2002 to 2009, my father battled his illness with great determination and faith in God. Though he is no longer with us, his legacy, his love will forever be with us. Rest in peace Pappy.– Bettina